Cynata is an Australian stem cell and regenerative medicine company.
The halt will remain in place until the opening of trade on Monday 23rd January 2017, or earlier if an announcement is made to the market.
Cynata Therapeutics to raise capital
Cynata Therapeutics (ASX:CYP) has been granted a trading halt by the ASX, pending details on a capital raising.